Autologous Rectus Fascia
Rectus fascia is the patient's own abdominal-wall fascia, usually harvested from the anterior sheath for a pubovaginal sling. It is an established option for female stress urinary incontinence (SUI). Other applications, including prolapse and penile reconstruction, have a smaller and less comparative evidence base. A free fascial graft is distinct from a vascularized rectus muscle or myofascial flap.
Use the autologous pubovaginal sling procedure for placement and tensioning. This page addresses the graft, harvest trade-offs and material-specific evidence.
Benefits and Risks
Autologous fascia avoids implantation of a synthetic sling mesh and donor-tissue transmission concerns. It does not guarantee absence of inflammation, infection, pain, graft failure or urinary-tract injury. Permanent fixation sutures may still be used, and postoperative obstruction or recurrent incontinence can require further treatment.
The AUA/SUFU guideline includes autologous fascia PVS among options for index SUI patients. It advises against synthetic MUS during concomitant urethral diverticulectomy, urethrovaginal fistula repair or urethral mesh excision; if concurrent continence surgery is appropriate, autologous fascia is preferred over other biological substitutes. A remote healed urethral operation is a different situation. Poor urethral mobility and compromised tissue require individualized choices; radiation or steroid exposure also affects autologous healing.[1]
The FDA's 2019 transvaginal POP mesh action should not be described as a ban on all sling or sacrocolpopexy mesh. Route and indication matter when discussing material options.[2]
Harvest Planning
Inspect prior abdominal scars, hernia repair, mesh, fascial quality and potential future flap needs. A transverse lower-abdominal incision exposes the anterior sheath; dimensions depend on the operation and available tissue. Published sling techniques describe approximately 10 cm of fascia, but this is not a universal size or proof that the same harvest fits every abdominal wall.[3][4]
Clarify the dimensions of the proposed nerve “safety zone.” In 12 female anatomical donors, Cardenas-Trowers et al. modeled a site 5.4 cm above the pubic symphysis, where the graft's inferior edge could be 9.4 cm long across the midline. The 9.4 cm measurement is transverse length, not a second vertical landmark. Their closer-to-pubis estimate relied on extrapolation. These cadaveric averages do not guarantee nerve preservation in an individual patient and were not a hernia-prevention trial.[3]
Preserve viable fascial edges and close the donor defect with an appropriate abdominal-wall technique. Counsel about hematoma, wound infection/dehiscence, pain, sensory change and incisional hernia. Fascia lata is an alternative when the abdominal donor site is unsuitable; it substitutes thigh morbidity for abdominal harvest morbidity.[1]
Female SUI: Evidence That Helps Counseling
| Evidence | Result and interpretation |
|---|---|
| SISTEr randomized trial: 655 women | At 24 months, autologous rectus PVS had greater SUI-specific success than Burch colposuspension: 66% versus 49%. The stricter overall continence outcome was 47% versus 38%. Outcome assessment was available for 520 women; UTI, voiding difficulty and postoperative urgency incontinence were more frequent after the sling.[5] |
| Khan long-term randomized-cohort follow-up: 162/201 respondents | At median 10 years, dry or improved was 75.4% after autologous fascia versus 73% after TVT; completely dry was 50.8% versus 31.7%. No further operation for persistent SUI was reported in the autologous arm. This does not mean no reoperations or complications of any kind.[6] |
| E-SISTEr observational extension: 482 enrolled | Continence declined over time, while most respondents remained satisfied. The five-year cumulative composite continence estimate was 30.8% after sling versus 24.1% after Burch; these estimates retain prior failure and do not represent cross-sectional dryness. At the five-year visit, satisfaction was 83% (148/179) versus 73% (126/172) among respondents. The endpoint differed from the original trial, and women with persistent incontinence were more likely to enroll. These are not interchangeable “cure rates.”[7] |
| 2020 Cochrane traditional-sling review | 34 trials/3,244 women, with the clinical search fully incorporated only through February 2017. Supports a continence/voiding-morbidity trade-off versus open colposuspension; MUS comparisons remain uncertain. Historical autologous, donor-derived and synthetic materials are mixed, so its pooled findings are not an autologous-rectus-only estimate or proof of donor-tissue equivalence.[18] |
| 2024 randomized-trial review | No statistically clear cure difference was detected between autologous fascia and synthetic midurethral slings. Operative time, hospital stay and de novo urgency favored synthetic slings; reported long-term complications favored fascia. Heterogeneous procedures and outcome definitions prevent a blanket claim of equal efficacy or universally lower morbidity.[8] |
Placement and postoperative emptying
Classic PVS supports the bladder neck/proximal urethra; short midurethral fascial slings are modifications, not identical operations. Cystoscopy checks lower-tract integrity after retropubic passage. It does not replace deliberate sling tensioning or a postoperative voiding assessment.[1][4]
Osman's retrospective midurethral series included 106 patients with mean nine-month follow-up. Primary and previously operated SUI subgroups had different cure and catheterization results; the favorable primary-SUI figures should not be applied to every salvage case. The 2024 review of autologous transobturator slings likewise emphasized limited-quality, mostly short-term evidence rather than proven long-term equivalence to synthetic tapes.[9][10]
Prolapse Reconstruction
Rectus fascia can be used in selected sacrocolpopexy or vaginal reconstructive techniques when the patient wishes to avoid synthetic mesh. This does not establish that it has the same durability as mesh, or that it is preferred for every patient with a mesh-risk factor.
In Wang's single-center 132-patient cohort, median follow-up was 2.2 years. Five-year survival estimates were 28.3% composite failure, 6.8% anatomic failure and 13.0% retreatment, with wide confidence intervals. Quoting only anatomic failure would conceal symptomatic and retreatment outcomes.[11]
Cormio's 30-patient pubovaginal cystocele-sling series reported no anterior recurrence at mean 62.6 months, with one apical/posterior recurrence and one superficial donor-wound dehiscence. This specialized uncontrolled series is not a universal 100% prolapse-success benchmark.[12]
Other Reconstructive Uses
| Application | Evidence boundary |
|---|---|
| Peyronie/tunical grafting | A cadaveric comparison and 12-patient series using the dorsal rectus sheath found similar histological architecture to tunica and straightening in 10 patients; six had minor complications. Histological resemblance does not establish an ideal graft or protection from erectile dysfunction.[13] |
| Corporal coverage during penile prosthesis placement | Pathak's 15-patient fibrosis series reported functioning implants without graft-related infection/erosion at mean 18 months. It establishes feasibility in selected reconstructions, not universal success or absence of future prosthesis complications.[14] |
| Neurogenic bladder-neck sling/cinch | Increasing outlet resistance requires assessment of bladder storage pressures, upper tracts and a catheterization plan. In Bugg's 15 children undergoing concurrent augmentation, nine were dry by the study definition; the authors subsequently changed their technique because results did not meet expectations.[15] |
| Vascularized myofascial wrap | A pedicled rectus muscle/sheath construct is a flap with its own blood supply and different harvest burden; outcomes cannot be pooled with free fascia grafts.[16] |
| Recurrent metoidioplasty fistula | Johnsen reported no recurrence in three patients at median seven months. Free fascia separates suture lines but does not provide the vascular supply of a pedicled interposition flap.[17] |
Document the actual tissue source, graft dimensions, fixation material, donor-site closure and any associated reconstructive procedure.
References
1. American Urological Association/SUFU. Surgical Treatment of Female Stress Urinary Incontinence. 2023 amendment. Statements 12, 16–18 and autologous fascia PVS discussion. Guideline.
2. US Food and Drug Administration. Pelvic Organ Prolapse (POP): Surgical Mesh Considerations and Recommendations. Regulatory overview.
3. Cardenas-Trowers OO, Bergden JS, Gaskins JT, et al. Development of a Safety Zone for Rectus Abdominis Fascia Graft Harvest Based on Dissections of the Ilioinguinal and Iliohypogastric Nerves. American Journal of Obstetrics and Gynecology. 2020;222(5):480.e1-480.e7. doi:10.1016/j.ajog.2019.12.009
4. Miller AR, Linder BJ, Lightner DJ. Autologous Rectus Fascia Sling Placement in the Management of Female Stress Urinary Incontinence. International Urogynecology Journal. 2018;29(9):1403-1405. doi:10.1007/s00192-018-3643-1
5. Albo ME, Richter HE, Brubaker L, et al. Burch Colposuspension versus Fascial Sling to Reduce Urinary Stress Incontinence. N Engl J Med. 2007;356:2143–2155. doi:10.1056/NEJMoa070416.
6. Khan ZA, Nambiar A, Morley R, et al. Long-Term Follow-Up of a Multicentre Randomised Controlled Trial Comparing Tension-Free Vaginal Tape, Xenograft and Autologous Fascial Slings for the Treatment of Stress Urinary Incontinence in Women. BJU International. 2015;115(6):968-977. doi:10.1111/bju.12851
7. Brubaker L, Richter HE, Norton PA, et al. Five Year Continence Rates, Satisfaction and Adverse Events of Burch Urethropexy and Fascial Sling Surgery for Urinary Incontinence. J Urol. 2012;187:1324–1330. doi:10.1016/j.juro.2011.11.087. Full text.
8. Grigoryan B, Kasyan G, Pushkar D. Autologous Slings in Female Stress Urinary Incontinence Treatment: Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Urogynecology Journal. 2024;35(4):759-773. doi:10.1007/s00192-024-05768-6
9. Osman NI, Hillary CJ, Mangera A, et al. The Midurethral Fascial "Sling on a String": An Alternative to Midurethral Synthetic Tapes in the Era of Mesh Complications. European Urology. 2018;74(2):191-196. doi:10.1016/j.eururo.2018.04.031
10. Vasudeva P, Yadav S, Sinha S, et al. Autologous Versus Synthetic Midurethral Transobturator Sling: A Systematic Review and Meta-Analysis of Outcomes. Neurourology and Urodynamics. 2024;43(8):2017-2029. doi:10.1002/nau.25527
11. Wang R, Reagan K, Boyd S, Tulikangas P. Sacrocolpopexy Using Autologous Rectus Fascia: Cohort Study of Long-Term Outcomes and Complications. BJOG. 2022;129(9):1600-1606. doi:10.1111/1471-0528.17107
12. Cormio L, Mancini V, Liuzzi G, Lucarelli G, Carrieri G. Cystocele Repair by Autologous Rectus Fascia Graft: The Pubovaginal Cystocele Sling. The Journal of Urology. 2015;194(3):721-727. doi:10.1016/j.juro.2015.03.104
13. Craatz S, Spanel-Borowski K, Begemann JF, et al. The Dorsal Lamina of the Rectus Sheath: A Suitable Grafting Material for the Penile Tunica Albuginea in Peyronie's Disease? BJU International. 2006;97(1):134-137. doi:10.1111/j.1464-410X.2006.05876.x
14. Pathak AS, Chang JH, Parekh AR, Aboseif SR. Use of Rectus Fascia Graft for Corporeal Reconstruction During Placement of Penile Implant. Urology. 2005;65(6):1198-1201. doi:10.1016/j.urology.2004.12.062
15. Bugg CE, Joseph DB. Bladder Neck Cinch for Pediatric Neurogenic Outlet Deficiency. The Journal of Urology. 2003;170(4 Pt 2):1501-1503. doi:10.1097/01.ju.0000084145.34813.97
16. Kolligian ME, Palmer LS, Cheng EY, Firlit CF. Myofascial Wrap to Treat Intractable Urinary Incontinence in Children. Urology. 1998;52(6):1122-1127. doi:10.1016/s0090-4295(98)00490-7
17. Johnsen NV, Voelzke BB. Autologous Rectus Fascia Graft Interposition Repair of Urethrocutaneous Fistulae in Female-to-Male Metoidioplasty Patients. Urology. 2018;116:208-212. doi:10.1016/j.urology.2018.03.013
18. Saraswat L, Rehman H, Omar MI, et al. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2020;1:CD001754. doi:10.1002/14651858.CD001754.pub5. Full text.